Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

Nature Medicine
L HolcombK Duff

Abstract

Genetic causes of Alzheimer's disease (AD) include mutations in the amyloid precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2) genes. The mutant APP(K670N,M671L) transgenic line, Tg2576, shows markedly elevated amyloid beta-protein (A beta) levels at an early age and, by 9-12 months, develops extracellular AD-type A beta deposits in the cortex and hippocampus. Mutant PS1 transgenic mice do not show abnormal pathology, but do display subtly elevated levels of the highly amyloidogenic 42- or 43-amino acid peptide A beta42(43). Here we demonstrate that the doubly transgenic progeny from a cross between line Tg2576 and a mutant PS1M146L transgenic line develop large numbers of fibrillar A beta deposits in cerebral cortex and hippocampus far earlier than their singly transgenic Tg2576 littermates. In the period preceding overt A beta deposition, the doubly transgenic mice show a selective 41% increase in A beta42(43) in their brains. Thus, the development of AD-like pathology is substantially enhanced when a PS1 mutation, which causes a modest increase in A beta42(43), is introduced into Tg2576-derived mice. Remarkably, both doubly and singly transgenic mice showed reduced spontaneous alternation performance in a "Y...Continue Reading

References

Jun 6, 1995·Proceedings of the National Academy of Sciences of the United States of America·P M MoranP C Moser
Apr 1, 1997·Trends in Neurosciences·J Hardy
Jun 27, 1997·The Journal of Biological Chemistry·C Wild-BodeC Haass
Nov 19, 1997·The Journal of Comparative Neurology·M N GordonD G Morgan

❮ Previous
Next ❯

Citations

Feb 23, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·M E Gurney
Feb 20, 2010·Experimental Brain Research·Paul E GottschallLauren A Bailey
Feb 2, 2008·European Journal of Nuclear Medicine and Molecular Imaging·Thomas M WengenackJoseph F Poduslo
Jan 26, 2008·European Journal of Nuclear Medicine and Molecular Imaging·A WinkelerA H Jacobs
Jan 13, 2005·Acta Neuropathologica·Khalid Iqbal, Inge Grundke-Iqbal
Nov 27, 2007·Acta Neuropathologica·Charles DuyckaertsBenoît Delatour
Apr 24, 2009·Acta Neuropathologica·Henning BreyhanThomas A Bayer
Apr 1, 2010·Acta Neuropathologica·Gunnar K GourasEstibaliz Capetillo-Zarate
Jul 16, 2010·Acta Neuropathologica·Delphine BocheJames A R Nicoll
Dec 17, 2009·Brain Structure & Function·Thomas Wisniewski, Allal Boutajangout
Oct 14, 2009·Journal of Neural Transmission·Oliver WirthsThomas A Bayer
Oct 31, 2006·Behavior Genetics·Jason L Eriksen, Christopher G Janus
Nov 28, 2007·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Donna L HerberMarcia N Gordon
Jul 9, 2008·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Rachel A KarlnoskiDave Morgan
Mar 20, 2002·Current Neurology and Neuroscience Reports·C JanusD Westaway
Aug 10, 2002·Current Neurology and Neuroscience Reports·Joanna L JankowskyDavid R Borchelt
Sep 6, 2002·Journal of Molecular Neuroscience : MN·Suzana S PetanceskaLorenzo M Refolo
Mar 23, 2011·Molecular Neurobiology·Daniel W WessonDonald A Wilson
Aug 24, 2012·Molecular Neurobiology·Robert NisticòGraham Collingridge
Jun 25, 2009·Neurotoxicity Research·Leslie CrewsEliezer Masliah
Dec 21, 2010·Journal of Applied Genetics·Ivan A Borbon, Robert P Erickson
Jun 24, 2004·Neurobiology of Aging·Sherri DudalFrancine Gervais
Aug 18, 2004·Neurobiology of Aging·Huw D LewisMark S Shearman
Jul 29, 2005·The American Journal of Pathology·Samir Kumar-SinghChristine Van Broeckhoven
Nov 26, 2003·Experimental Neurology·Véronique BlanchardLaurent Pradier
Dec 3, 1999·Journal of the Neurological Sciences·O CombarrosA Carvajal
Sep 22, 2001·Physiology & Behavior·C Janus, D Westaway
May 22, 2002·Physiology & Behavior·David L King, Gary W Arendash
Feb 26, 2000·Mechanisms of Ageing and Development·L A HolcombD G Morgan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.